ASMB
Assembly BiosciencesยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ASMB Profile
Assembly Biosciences, Inc.
A clinical-stage biotechnology company that develops therapeutics targeting hepatitis B virus and other viral diseases
Two Tower Place, 7th Floor, South San Francisco, California 94080
--
Assembly Biosciences, Inc., incorporated in Delaware on October 7, 2005, began operations in April 2007. The company is a biopharmaceutical company advancing clinical drug candidates that have the potential to improve the lives of millions of people living with chronic hepatitis B virus (HBV) worldwide, an early development program for highly recurrent genital herpes associated with herpes simplex virus (HSV-2) infection, a research program focused on the discovery of novel antiviral drugs for the treatment of destructive viral diseases, Including delta hepatitis virus (HDV) and transplantation-associated herpes virus.
